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P.L. Chong, K. Salhiyyah and P.D.F. Dodd*Sheffield Vascular Institute, Northern General Hospital, Sheffield, UKObjective. Carotid artery angioplasty and stenting (CAS) has been proposed as an alternative to surgery for patients with
high-grade symptomatic carotid disease. The purpose of this study was to determine the proportion of patients that were
suitable for each type of intervention and to analyse the reasons that precluded stenting.
Materials and methods. This was a prospective observational study. All patients considered for intervention for carotid
artery disease during an 18-month period were analysed. The management decision was recorded, as were the reasons for
unsuitability for stenting.
Results. Two hundred and sixty-eight patients’ data were analysed, 224 had complete records. Forty-seven patients did not
require intervention and received best medical treatment alone. One hundred and seventy-seven patients required
intervention, 113 were suitable for stenting and 64 were not. In 51 patients stenting was preferred. Sixty-two patients were
suitable for either stent or surgery. Sixty-four patients were unsuitable for stenting. Carotid tortuosity and proximal disease
accounted for 70% of this group.
Conclusions. Current enthusiasm for carotid stenting might well be supported by the results of ongoing randomised-
controlled clinical trials. However, this study highlights a significant proportion (64/177; 36%) of our patients is presently
unsuitable for stenting. The common technical difficulties and limitations of stenting encountered in our unit are related
predominantly to carotid anatomy.Keywords: Carotid endarterectomy; Carotid stend; Audit.Introduction
Two large randomised clinical trials have established
carotid endarterectomy (CEA) for recently sympto-
matic high-grade carotid artery stenosis. These trials,
the European carotid surgery trial (ECST) and the
North American symptomatic carotid endarterectomy
trial (NASCET), have shown that the risk of stroke is
significantly reduced by carotid endarterectomy com-
pared with medical therapy alone in patients with
symptomatic, severe stenosis greater than 70%.1–4
Carotid artery angioplasty and stenting (CAS) has
been proposed as an alternative to surgery with a large
randomised trial showing equivalent short term
results: the carotid and vertebral artery transluminal
angioplasty study (CAVATAS).5 More recently, the
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paring carotid stenting (with emboli protection) versus
endarterectomy showed a significant advantage for
stenting in patients considered at high-risk for
surgery.6
In North America, the carotid revascularization
endarterectomy versus stent trial (CREST) is recruiting
lower-risk patients (who meet the NASCETcriteria for
surgery) for randomization.6 This might well deter-
mine whether carotid stenting will become a generally
acceptable alternative to surgery for carotid revascu-
larisation. In Europe, recruitment is underway for
three similar major, randomised, multi-centre trials:
the EVA3S study in France, the stent protected
angioplasty versus carotid endarterectomy (SPACE)
study in Germany and Austria, and the international
carotid stenting study (ICSS) based in Great Britain.7,8
Endovascular techniques are generally perceived to
be advantageous because they are minimally invasive
allowing a rapid return to normal activity. The costs
may be lower than that of surgery because of shorter
hospital stay and reduced use of high dependency
beds. At present, outside of randomised-controlled
clinical trials or well constructed audit in experiencedEur J Vasc Endovasc Surg 29, 597–600 (2005)
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in whom conventional surgical repair is deemed to be
high-risk.9 It is the recommendation of the Society of
Interventional Radiology that carotid angioplasty and
stenting be limited to haemodynamically significant
lesions with definite neurological or visual symptoms
attributable to that lesion, in patients who are at high-
risk for surgery or where surgical access is anticipated
to be difficult or hazardous.10 This is because of the
very low morbidity associated with carotid endarter-
ectomy when performed by experienced surgeons.
Carotid artery stenting for asymptomatic lesions is
controversial, however, the results of the SAPPHIRE
trial justify the use of protected CAS to treat asympto-
matic patients prior to coronary artery grafting.11
Widespread application of carotid stenting, there-
fore, awaits the completion of randomised prospective
trials and registry-type analyses in progress.12–14 Our
unit is active in carotid intervention and all our
patients are considered for endovascular treatment.
Nevertheless, stenting is not possible in all situations.
The purpose of this study was to determine the
proportion of patients that were suitable for each type
of intervention and to analyse the reasons that
precluded stenting.Fig. 1. Management algorithm for symptomatic carotid
disease.Materials and Methods
This was a prospective observational study per-
formed at a large university teaching hospital from
October 2001 to April 2003. All patients considered
for intervention for carotid artery disease underwent
arch aortography on an ‘intention-to-treat’ basis. A
consensus on the preferred treatment option and
the rationale for it was decided at a weekly
neurovascular multi-disciplinary team (MDT) meet-
ing, the results recorded prospectively and sub-
sequently analysed. The senior team members were
vascular surgeons, interventional vascular radiolo-
gists and neurologists.
Based on angiography some patients did not
require intervention and received best medical
treatment only i.e. risk-factor modification and
anti-platelet therapy. These patients had ipsilateral
internal carotid artery occlusion, no significant
stenosis (less than 70%) or were asymptomatic for
greater than 6 months.
For patients requiring intervention the first issue
addressed was suitability for stenting. Those unsui-
table for stenting required surgery. Of the others,
patients deemed high-risk for conventional surgical
treatment were preferably stented. The remainder,
suitable for either treatment were asked to enroll in aEur J Vasc Endovasc Surg Vol 29, June 2005randomised controlled trial comparing surgery with
stenting (currently in our unit the ICSS trial). This
management algorithm is shown in Fig. 1.
The cohort of patients who were unsuitable for
stenting was further analysed to find the reasons why
they were not randomised and surgery was the
preferred treatment option.Results
During the study period, 268 patients were discussed
at our MDT meetings. Records were complete for 224
patients. Ages ranged from 47 to 90 years (medianZ71
years); with amale:female ratio of 143:81 (64:36%). Left
cerebral hemisphere symptoms were more common
than right.
Forty-seven patients did not require intervention
and received best medical treatment alone. Of the
remaining 177 patients requiring intervention, 113
were suitable for stenting and 64 were not. In 51
patients, CAS was deemed preferable to CEA. Stenting
was preferred for patients with ‘hostile neck’ after
radiotherapy or previous surgery, restenosis following
previous CEA, significant co-morbidity, or prior to
coronary artery grafting.
Sixty-two patients were suitable for either stent or
surgery i.e. they were eligible for inclusion in a
randomised-controlled trial comparing carotid endar-
terectomy with stenting. These results are summarised
in Fig. 2.
Anatomical limitations accounted for the majority
of the 64 patients unsuitable for stenting. Carotid
tortuosity and proximal disease was identified in
45/64 or 70% patients. These results are summarised
in Table 1.
Fig. 2. Algorithmic representation of the number of patients
suitable for each intervention. ,—Highlights subset anal-
ysis group.
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Current enthusiasm for carotid stenting might well be
supported by the results of ongoing randomised-
controlled clinical trials such as CREST, ICSS and
others. However, this study shows that a significant
proportion (64/177; 36%) of our patients requiring
intervention for symptomatic carotid artery disease is
presently unsuitable for stenting. This cohort of
patients will remain unrepresented in any random-
ised-controlled trial comparing stenting with surgery
except in analysis of the CONSORT data.
The study highlights common technical difficulties
and limitations of stenting being encountered in our
unit. Vessel tortuosity prevents the safe deployment of
a neuro-protection device.15 Proximal disease of the
common carotid, brachiocephalic and aortic archTable 1. Patients not randomised because unsuitable for stenting
Contra-indication for stenting Patient
numbers
Percen-
tage (%)
Carotid tortuosity 29 45
Proximal arterial disease 16 25
Trickle flow 7 11
Carotid calcification 2 3
Impaired peripheral access (e.g.
occluded femoral arteries)
3 5
Re-stenosis in previous stent 1 1.5
Combined procedure 1 1.5
Carotid ectasia 1 1.5
Contrast hypersensitivity 1 1.5
Internal carotid thrombus 1 1.5
Patient agitation, confusion 1 1.5
Not recorded 1 1.5
Total 64 pts 100%arteries are associated with a significant risk of
embolisation. Trickle-flow predisposes to complete
thrombotic occlusion and presently there is no
consensus on how these should be managed.16 At
the time of the audit trickle-flow lesions were treated
by carotid endarterectomy in our unit. The study also
shows the need for future technological development,
to facilitate the stenting of tortuous and kinked,
stenotic carotid arteries.17
Comparatively fewer carotid endarterectomies are
being performed in our unit. However, this study also
highlights the continued role for carotid endarterect-
omy despite our activity in endovascular intervention.
We conclude that at least for the foreseeable future
there is a need to teach vascular surgical trainees to
perform carotid endarterectomy competently and
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